Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 275 Carcinoma, Intraductal, Noninfiltrating 25 Breast Carcinoma In Situ 21 Breast Neoplasms, Male 12 Neoplasm Metastasis 10 Neoplasms 7 Inflammatory Breast Neoplasms 7 Breast Cancer Female 4 Obesity 3 Endometrial Neoplasms 3 Carcinoma, Ductal, Breast 3 Breast Diseases 3 Sleep Wake Disorders 2 Hot Flashes 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Risk Reduction Behavior 1 Recurrence 1 Pulmonary Fibrosis 1 Primary Breast Cancer 1 Premenopausal Breast Cancer 1 Precancerous Conditions 1 Patient Acceptance of Health Care 1 Paget's Disease, Mammary 1 Ovarian Neoplasms 1

Interventions

Therapeutics 2 Psychiatric Rehabilitation 2 Letrozole 2 Goserelin 2 Cyclophosphamide 2 Tamoxifen 1 Neoadjuvant Therapy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Infertility × Tamoxifen × Breast × Clear all

NCT03011684 2026-06-04

TALES

University of California, San Francisco

Phase 3 Recruiting

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon ⚡